Aurora Cannabis’ Non Cannabis Revenue (2018-2022)

This statistic highlights Aurora Cannabis’ Non Cannabis Revenue, reported on a quarterly basis from 2018 Q1 onwards.

Aurora Cannabis’ Non Cannabis Revenue

Aurora Cannabis mainly operates in the Cannabis segment that involves support activities like patient counseling services, design, analytical testing services, engineering, and consulting services, etc. Non-cannabis revenue segment includes revenue from patient referrals and construction consulting services provided to consumers. Also, this segment includes revenue from using non-cannabis plants. As per the recent revenue trend, Aurora generated about 61% of revenue from Cannabis products whereas Aurora Cannabis 33% in the last quarter of FY19.

Cannabis and Non-cannabis products

Cannabis is a psychoactive drug that is also known as ‘marijuana’. The cannabis plant is used for recreational and medicinal purposes. Also, cannabis can be used in cigarettes, foods, for vaporizing and as an extract. Uses of cannabis do not end in recreational and medicinal drugs, it may also be used for spiritual purposes. It is an illegal drug that is widely used in the United States and around the world. Cannabis drugs are used in fighting diseases like diabetes, cancer, glaucoma, ADHD and ADD.

Non-cannabis are plants that do not have cannabis element but has cannabinoids, which makes it similar to cannabis. Some of the known cannabis plants are Echinacea, Electric daisy, Chocolate, Black pepper, and many others. Most of these non-cannabis plants have similar characteristics as cannabis plants. These plants regulate the immune system and reduce the inflammatory response in our bodies. Also, they act as a strong painkilling agent and treats bronchitis as well as bladder problems.

About Aurora Cannabis

Aurora Cannabis Inc. is a legally authorized Canadian cannabis producer. Its headquarters is located in Edmonton. This company is listed in New York Stock Exchange (NYSE), Toronto Stock Exchange (TSX), and Frankfurt Stock Exchange (FSE) under different trading brands. Aurora Cannabis’s main business line is the production, sale, and distribution of cannabis products in Canada and internationally. Aurora was set up in 2006 by Steve Dobler, Terry Booth, Chris Mayerson, and Dale Lesack. In 2014, the company received the license to grow Cannabis which enabled Aurora to produce and sell Cannabis and Non-Cannabis products to consumers for medicinal purposes.

Aurora Cannabis is the second-largest cannabis providing company in the world just behind Canopy Growth Corporation. Aurora is one of the world’s fastest and large cannabis supplying company. The Company has expanded organically as well as through strategic acquisitions to create a world standard cultivation platform that produces best-quality and consistent cannabis for the international medical market and Canadian consumer use.

Did you like Aurora Cannabis’ Non Cannabis Revenue statistic?

Access more such KPI data points and segment financials on thousands of US stocks, with Business Quant.

You can get started here.